Dicerna Pharmaceuticals, Inc. Debt to Equity Ratio 2013-2021 | DRNA
Current and historical debt to equity ratio values for Dicerna Pharmaceuticals, Inc. (DRNA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Dicerna Pharmaceuticals, Inc. debt/equity for the three months ending September 30, 2021 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2021-09-30 |
$0.66B |
$0.11B |
6.17 |
2021-06-30 |
$0.73B |
$0.11B |
6.55 |
2021-03-31 |
$0.56B |
$0.13B |
4.41 |
2020-12-31 |
$0.57B |
$0.14B |
4.14 |
2020-09-30 |
$0.53B |
$0.15B |
3.44 |
2020-06-30 |
$0.57B |
$0.16B |
3.52 |
2020-03-31 |
$0.60B |
$0.18B |
3.38 |
2019-12-31 |
$0.45B |
$0.15B |
2.93 |
2019-09-30 |
$0.20B |
$0.13B |
1.50 |
2019-06-30 |
$0.20B |
$0.16B |
1.26 |
2019-03-31 |
$0.20B |
$0.18B |
1.14 |
2018-12-31 |
$0.21B |
$0.20B |
1.04 |
2018-09-30 |
$0.03B |
$0.16B |
0.19 |
2018-06-30 |
$0.03B |
$0.07B |
0.39 |
2018-03-31 |
$0.02B |
$0.09B |
0.18 |
2017-12-31 |
$0.02B |
$0.10B |
0.20 |
2017-09-30 |
$0.09B |
$-0.00B |
-22.89 |
2017-06-30 |
$0.08B |
$0.01B |
6.14 |
2017-03-31 |
$0.01B |
$0.03B |
0.36 |
2016-12-31 |
$0.01B |
$0.04B |
0.24 |
2016-09-30 |
$0.01B |
$0.05B |
0.19 |
2016-06-30 |
$0.01B |
$0.07B |
0.14 |
2016-03-31 |
$0.01B |
$0.08B |
0.09 |
2015-12-31 |
$0.01B |
$0.09B |
0.10 |
2015-09-30 |
$0.01B |
$0.10B |
0.09 |
2015-06-30 |
$0.01B |
$0.12B |
0.08 |
2015-03-31 |
$0.01B |
$0.09B |
0.07 |
2014-12-31 |
$0.01B |
$0.10B |
0.05 |
2014-09-30 |
$0.01B |
$0.11B |
0.05 |
2014-06-30 |
$0.00B |
$0.12B |
0.03 |
2014-03-31 |
$0.01B |
$0.13B |
0.05 |
2013-12-31 |
$0.01B |
$0.04B |
0.21 |
2013-09-30 |
$0.01B |
$0.05B |
0.18 |
2013-06-30 |
$0.00B |
|
0.00 |
2013-03-31 |
$0.00B |
|
0.00 |
2012-09-30 |
$0.00B |
|
0.00 |